Track market-moving stories before they get noisy

Nelson Peltz's Trian Fund Management has no plans to make ‌a take-private bid for Wendy's (WEN.O) at this time, sources familiar with the matter told Reuters.

The move comes after the investment firm, a longtime Wendy's shareholder with around 16% of the fast food chain, was earlier this month reported by Reuters and others to ​be working on preparing a bid with the help of a consortium of investors, including Bugatti-backed BlueFive Capital ​and Flynn Group, a Wendy's franchisee.

News of a possible take-private sent the stock up ⁠14.7% on August 12, with further momentum since pushing it to around a nine-month high, leaving the company ​with a market value of around $1.7 billion.

On Wednesday Wendy's stock price tumbled more than 14% in after-hours trading in ​reaction to the Trian news.

Trian has concerns about Wendy's performance, including its recent trading price and valuation multiples, as well as its current strategic direction, said the sources who are familiar with the matter but cannot discuss Trian's thinking publicly.

This leaves Trian keeping ​an open mind about its future intentions, the sources added, declining to elaborate further.

A representative for Trian declined ​to comment.

Wendy's did not immediately respond to a request for comment.

SACRIFICING QUALITY
By pulling back on a possible takeover offer, Trian could ‌be offering ⁠new Wendy's Chief Executive Bob Wright time to execute a turnaround plan to address declining sales that cost it the No. 2 spot among big burger chains.

On Monday, Wright issued a rare corporate mea culpa, telling the Wall Street Journal that the chain sacrificed quality to trim costs. He also rolled out a five-point plan to ​revive prospects.

Earlier in August, Wendy's reported ​a drop in quarterly ⁠global sales, lower net income, higher costs and a drop in earnings per share, all of which prompted Wright to say the company is "clearly not performing at (its) potential."

Wright, ​who took the top job in May, is the fourth leader of Dublin, Ohio-headquartered ​Wendy's in ⁠the last three years.

Even as takeover speculation helped support the stock price, Wendy's shares still trade roughly 60% lower than they did five years ago.

Wendy's has had a nearly two-decade-long relationship with Trian, with Trian co-founder Peter May sitting on ⁠its ​board for 18 years. Last year, Bradley Peltz, one of Nelson Peltz's ​sons, joined the nine-person board. Nelson Peltz and another son, Matthew, had previously held board seats.

Trian also mulled taking Wendy's private in 2022 ​and then backed away from such plans in 2023.

3 Beaten Up Experiential Stocks to Cash in on a Good TimeBowlero NYSE: BOWL, operating as Lucky Strike Entertainment, said fiscal 2026 revenue rose 4% to $1.245 billion while adjusted EBITDA reached $333 million, as improved bowling, food, league and event trends were partly offset by a late-year disruption from major televised sports and weather pressure at its water parks.

For the fiscal year ended June 29, 2026, same-store sales declined 0.2%, an improvement of 3.5 percentage points from the prior year and the company’s strongest comparable-sales result since fiscal 2023, according to Founder and Chief Executive Thomas Shannon. Excluding California, same-store sales increased 0.9%.

Get Bowlero alerts:

Bowlero is Quietly Cornering The Bowling MarketShannon said retail bowling and shoe revenue increased 2.9% on a comparable basis, league revenue rose 3.6%, and food sales increased 8%. Events, which management has identified as a key growth opportunity after a multiyear decline, turned positive in May and June and remained positive in July and August.

Sports Viewership Pressured June Results Management said fourth-quarter trends began positively, with April roughly flat and May up 2%, before major sports programming affected customer traffic. Shannon attributed a 7% comparable-sales decline in June to record viewership for the World Cup and the New York Knicks’ NBA championship run.

“For five straight weeks, millions of consumers who would ordinarily be bowling on a Friday or Saturday night were watching sports from home,” Shannon said. He described the impact as a one-time programming event rather than evidence of a weakening consumer, adding that trends improved after the World Cup final and August results were rebounding.

President and Chief Financial Officer Bobby Lavan estimated that the World Cup affected June revenue by at least $7 million, potentially as much as $10 million to $12 million. He also cited approximately $10 million of weather-related revenue pressure from two snowstorms during the March quarter.

California remained the company’s weakest market, with comparable sales down 4% during fiscal 2026, compared with a 1% increase for the rest of the company. Lavan said California accounts for about 20% of the business. The company has replaced leadership in the state and is overhauling its corporate sales organization there, though management is not including a California turnaround in its fiscal 2027 forecast.

Water Parks Face Weather Challenges but Grow EBITDA Lucky Strike expanded its directly managed water-park portfolio to five locations during the summer, including Raging Waters Los Angeles, acquired in January for $45 million. The company said water parks generated $56 million in trailing 12-month revenue through July and $22 million in EBITDA, compared with $23 million in revenue and $11 million in EBITDA in fiscal 2025.

Per-capita spending across the water-park portfolio increased by double digits, while payroll declined by the mid-single digits as staffing was aligned with demand. However, attendance was affected by weather, including cool and wet conditions near Chicago at Raging Waves and lower-than-ideal temperatures in Los Angeles.

Shannon said the company plans to sell season passes earlier for the next season, viewing passes as a way to reduce weather-related revenue volatility. Management also expects to better balance season-pass volume and pricing after placing more emphasis on premium pricing this year.

Its Boomers family entertainment centers generated $11 million in EBITDA during the year, nearly double the prior-year result, according to Shannon. The company said the businesses are counter-seasonal to bowling operations and were EBITDA-positive in every period.

Fiscal 2027 Outlook and Investment Plans Lucky Strike forecast fiscal 2027 adjusted EBITDA of $340 million to $360 million and expects same-store sales growth of 1% to 3% through the year. Management characterized its EBITDA outlook as conservative, reflecting uncertainty around consumer conditions and weather rather than a change in its operating plan.

Lavan said the December quarter will be a critical test for the restructured events business. Event bookings entering the end of September were tracking 10% higher than the prior year, compared with a 30% decline in the prior-year period. Events accounted for about 40% of revenue in December, he said.

The company has reorganized its events sales operation into a hybrid structure that separates larger corporate accounts from localized business and uses a call center for smaller parties. Management said it sees an opportunity to recover roughly $40 million in event revenue lost over the past three years.

Lucky Strike also plans to launch a new customer relationship management system in October. Lavan called it the company’s largest IT initiative to date, with related spending weighing on selling, general and administrative expenses in the June and September quarters.

Fiscal 2027 capital expenditures are budgeted at $90 million, down from $114 million in fiscal 2026 and $194 million two years earlier. Management expects long-term annual capital expenditures to move toward $70 million to $80 million after its rebranding cycle is completed. The company expects to finish consolidating its branding around Lucky Strike and AMF by the end of fiscal 2027. Lucky Strike expects water parks to contribute $28 million to $33 million of EBITDA in fiscal 2027 and Boomers to contribute roughly $10 million to $15 million. Portfolio and Cash Flow Focus Shannon said the company remains open to acquisitions but is pursuing them only opportunistically while it focuses on improving the current portfolio, growing organic EBITDA and reducing leverage. He said Lucky Strike may shed approximately 10 properties during fiscal 2027, primarily peripheral locations acquired during a prior period of active dealmaking.

The company has only two or three EBITDA-negative centers, according to Shannon. Lavan said potential asset sales could be used to reduce leverage where sales values are attractive relative to the cost of supporting fringe locations.

In response to an analyst’s free-cash-flow estimate, Lavan said approximately $50 million for fiscal 2027 was a fair assumption, excluding any asset sales. He said the company’s goal is to pay down its revolving credit facility by June.

About Bowlero (NYSE:BOWL)Bowlero Corporation operates one of the largest bowling center networks in North America, offering an array of bowling and entertainment experiences under its Bowlero, Bowlmor Lanes and AMF Bowling brands. The company's venues combine traditional ten-pin bowling with modern amenities such as full-service bars, food and beverage offerings, premium bowling lanes, and private event spaces. Bowlero also enhances guest experiences through live entertainment, arcade games, billiards tables and league-play programs tailored for casual bowlers and competitive enthusiasts alike.

Since its origins in the mid-20th century as AMF Bowling, the business underwent a series of strategic transformations, including a merger with boutique operator Bowlmor Lanes and a subsequent rebranding initiative that introduced the Bowlero concept in the late 2010s.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Bowlero Right Now?Before you consider Bowlero, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowlero wasn't on the list.

While Bowlero currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Key Takeaways Amphenol's Communications Solutions revenues jumped 85% year over year, led by AI datacom demand.APH expects another mid-teen sequential IT datacom increase in Q3 as AI data-center investments accelerate.Amphenol strengthened its AI connectivity position with CommScope and Wilder Technologies acquisitions. Amphenol (APH - Free Report) is riding on strong growth in its Communications Solutions segment, supported by surging AI-related IT datacom demand and contributions from acquisitions. In the second quarter of 2026, Communications Solutions revenues jumped 85% year over year and 42% organically, representing roughly 62% of total revenues. Growth was primarily driven by outsized IT datacom demand, particularly for AI applications, along with strength in industrial, mobile-device and automotive markets.

AI infrastructure remains the biggest growth engine and is helping the company fight off competition from the likes of TE Connectivity (TEL - Free Report) and Bel Fuse (BELFB - Free Report) . IT datacom accounted for 43% of Amphenol’s quarterly sales and grew 89% year over year and 63% organically. Sequential growth reached 22%, with virtually all of the increase attributed to AI-related products. Amphenol expects another mid-teen sequential increase in the third quarter as AI data-center investments accelerate and cloud and enterprise customers expand infrastructure spending. Its exposure spans high-speed copper, fiber-optic and power interconnect solutions, allowing it to capture rising connectivity content across AI systems.

Acquisitions are further strengthening this position. CommScope’s IT datacom business, focused on advanced optical interconnect solutions, nearly doubled year over year, while Amphenol raised CommScope’s expected 2026 revenues to $4.6 billion from $4.1 billion. Wilder Technologies also expands APH’s capabilities in high-speed digital, RF and signal-integrity applications.

For the third quarter of 2026, APH expects sales of $9.3-$9.4 billion. The range implies year-over-year growth of 50-52%, assuming current market conditions and constant exchange rates. Adjusted earnings are projected between $1.40 and $1.42 per share, representing growth of 51-53% from the prior-year quarter.

How Rivals Stack Up Against APHTE Connectivity poses significant competition in AI connectivity. TEL’s Digital Data Networks revenues increased 34% year over year to $813 million in the third quarter of fiscal 2026, while Industrial Solutions revenues advanced nearly 22%. The company is benefiting from rising demand for connectivity technologies that distribute power, signal and data across AI-enabled data centers, with AI momentum helping drive record companywide orders of $5.7 billion, up 27% year over year.

Bel Fuse is a smaller but growing challenger. The company’s Data Solutions revenues surged 55% year over year to roughly $58 million as recent high-performance-computing project wins began ramping. Bel Fuse is also seeing stronger demand for integrated connector modules and RF connectors, while bookings remain strong across Data Solutions and distribution channels. This growing HPC and connectivity exposure could increase competitive pressure on APH for specialized interconnect and power content in next-generation computing infrastructure.

APH’s Share Price Performance, Valuation & EstimatesAmphenol’s shares have surged 17.5% year to date, outperforming the broader Zacks Computer & Technology sector’s return of 14.4%.

APH Stock’s Price Performance
Image Source: Zacks Investment Research

Amphenol shares are trading at a premium, as suggested by a Value Score of D. In terms of the forward 12-month price-to-earnings (P/E), APH is trading at 26.57X, higher than the broader sector’s 20.66.

APH Stock Is Overvalued
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Amphenol’s 2026 earnings is pegged at $5.25 per share, up 7.8% over the past 30 days. The figure indicates a 57.19% jump year over year.
 

APH currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways OPEN targets ANI breakeven by end-2026, based on 6,000 quarterly transactions and a $9B run rate.Contribution margin hit 5.8% as operating expense per acquisition fell to $3,000 in the second quarter.OPEN expects third-quarter contribution margin to moderate to 4-4.5% due to seasonality and Doma integration. Opendoor Technologies Inc. (OPEN - Free Report) has outlined a quantitative framework for reaching adjusted net income (ANI) breakeven on a 12-month go-forward basis by the end of 2026. The framework assumes roughly 6,000 quarterly transactions at $375,000 each, implying an annualized revenue run rate of approximately $9 billion.

Acquisition activity is moving toward the scale required by this model. OPEN generated 6,908 acquisition contracts in the second quarter, up from 5,136 in the first quarter. The company is also signing more than 500 contracts per week, with one recent week reaching roughly 700 — its highest weekly total in years. Still, contract volume does not translate directly into reported revenues. Some agreements will not close, while acquired homes generally progress through renovation, listing and resale before revenues are recognized.

Improving unit economics provides another important component of the profitability framework. Contribution margin reached 5.8% in the second quarter, within OPEN’s targeted 5-7% range. Operations expense per acquisition declined to $3,000 from $5,000 in the first quarter and $8,400 a year earlier. OPEN’s illustrative framework assumes that marketing, variable operations and fixed operating costs would represent a combined 2.9% of acquisition GMV. Based on the current dollar cost structure, these expenses would equal approximately 2.4% of revenues at a $9 billion run rate, below the 3-4% range previously associated with ANI profitability.

Still, maintaining these economics as volume expands will be critical. OPEN expects contribution margin to moderate to 4-4.5% in the third quarter because of seasonality and the temporary impact of the Doma integration. Net interest expense also remains slightly above 2% of revenues, increasing the importance of resale velocity and inventory discipline.

OPEN’s Breakeven Path Versus Zillow and OfferpadZillow Group, Inc. (ZG - Free Report) provides an adjusted-earnings benchmark, although its digital marketplace is less capital intensive than OPEN’s inventory-based iBuying model. Zillow reported second-quarter adjusted net income of $118 million and adjusted EBITDA of $176 million, translating into an adjusted EBITDA margin of 23%. Zillow also noted that Zillow Home Loans now generates positive unit economics across fixed and variable costs, highlighting the operating leverage available from integrated real estate services.

Offerpad Solutions Inc. (OPAD - Free Report) offers a more direct iBuying comparison. The company generated approximately $78 million in revenues from 295 real estate transactions and recorded an adjusted EBITDA loss of $6.2 million. Offerpad’s contribution profit after interest reached $13,500 per transaction. The company targets exiting 2026 at a run rate of roughly 1,000 quarterly transactions and attaining positive adjusted EBITDA on a year-end run-rate basis. Although Offerpad’s adjusted EBITDA objective is not directly comparable with OPEN’s adjusted net income target, both companies depend on transaction scale, resale velocity and disciplined inventory economics.

Taken together, OPEN’s higher contract activity, improved unit economics and lower operating expense per acquisition likely strengthen its prospects of reaching adjusted net income breakeven on a 12-month go-forward basis by year-end 2026.

OPEN’s Stock Price Performance, Valuation & EstimatesShares of Opendoor have declined 20.1% in the past year compared with the industry’s 13.7% fall.

OPEN One-Year Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, OPEN trades at a forward price-to-sales (P/S) multiple of 0.52, significantly below the industry’s average of 3.97.

OPEN’s P/S Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for OPEN's 2026 loss per share suggests a 42.3% year-over-year improvement. Loss per share estimates for 2026 have widened in the past 30 days.

EPS Trend of OPEN Stock
Image Source: Zacks Investment Research

It has been about a month since the last earnings report for Amkor Technology (AMKR - Free Report) . Shares have added about 6.6% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Amkor Technology due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Amkor Technology, Inc. before we dive into how investors and analysts have reacted as of late.

Amkor Technology Q2 Earnings Beat Estimates, Revenues Rise Y/YAmkor Technology reported second-quarter 2026 earnings of 70 cents per share, beating the Zacks Consensus Estimate by 48.94%. The company reported earnings of 22 cents per share in the year-ago quarter.

Net sales of $1.89 billion surpassed the Zacks Consensus Estimate by 5.27%. The figure increased 25.58% year over year. The quarter's performance reflected record revenues in the Computing and Automotive and Industrial end markets, along with continued strength across the advanced packaging portfolio.

AMKR's Q2 Top Line & MixAmkor's second-quarter 2026 revenue mix continued to skew toward higher value work. Advanced products totaled $1.557 billion, up 26.79% year over year, reflecting strong customer engagement across leading-edge packaging platforms. Mainstream products contributed $341 million, up 20.49% year over year, supported by the fifth consecutive quarter of year-over-year mainstream growth.

Packaging comprised 88% of second-quarter 2026 sales, in line with the year-ago period, and test services accounted for 12%. Net sales from the top 10 customers represented 66% in the second quarter of 2026 compared with 72% in the second quarter of 2025.

AMKR Q2 End Markets DetailsIn the second quarter, Communications revenues grew approximately 32% year over year, aided by double-digit growth in the iOS ecosystem even as Android softness stemming from memory supply constraints partly offset the gain.

Computing revenues rose approximately 26% year over year, hitting a record quarterly level on the back of broad-based data center demand and the ramp of the company's newest HDFO CPU program.

Automotive and Industrial revenues advanced approximately 38% year over year to a record quarterly level, driven by strong ADAS demand and increasing semiconductor content in next-generation vehicle platforms.

Consumer revenues declined approximately 2% year over year even as sequential demand improved on broad-based IoT strength across customers.

AMKR's Margin DetailsProfitability improved sharply from the year-ago period. Gross profit was $318.6 million, up 75.15% year over year, and gross margin expanded to 16.8%, up roughly 480 basis points year over year.

Operating income reached $199.9 million, more than double the $92 million reported in the year-ago quarter. Operating margin was 10.5%, up roughly 440 basis points year over year, reflecting higher factory utilization and a richer product mix.

Net income attributable to Amkor was $173.8 million compared with $54.4 million in the year-ago quarter. EBITDA was $400 million versus $259 million a year earlier.

AMKR's Balance Sheet & Cash Flow DetailsAmkor's liquidity position strengthened sequentially. As of June 30, 2026, total cash and short-term investments stood at $2.5 billion, up from $1.8 billion at the end of the first quarter, while total debt rose to $2.486 billion from $1.4 billion, following the issuance of $1.15 billion in convertible notes in May. Total liquidity was $3.6 billion, up from $2.9 billion in the prior quarter, and the debt-to-EBITDA ratio was 1.8X compared with 1.1X in the first quarter.

For the six months ended June 30, 2026, net cash provided by operating activities was $381.6 million, implying approximately $236.5 million was generated in the second quarter alone, up from $145.1 million in the first quarter. Capital expenditures for the six-month period totaled $688.4 million, implying approximately $463.8 million was invested in the second quarter, up from $224.6 million in the first quarter, consistent with the ongoing Arizona and Asia footprint expansion.

AMKR's Q3 & 2026 GuidanceFor the third quarter of 2026, AMKR expects net sales of $1.95-$2.05 billion and a gross margin of 18.5-19.5%. Net income is expected to be $180-$205 million, with diluted EPS between 72 cents and 82 cents.

Full-year 2026 capital expenditures remain projected at approximately $2.5-$3 billion, with roughly 65% to 70% allocated to facilities expansion, including Phase 1 of the Arizona campus and 30% to 35% allocated to HDFO, test and other advanced packaging capacity.

Operationally, management pointed to accelerating Computing growth of nearly 30% sequentially in the third quarter, driven by AI data center demand and the continued ramp of the HDFO CPU program, partly offset by a high single-digit sequential decline in Communications tied to the planned SiP transition from Korea to Vietnam and ongoing memory supply constraints. Recently announced 10-year and multi-year strategic partnerships with TSMC and NVIDIA were highlighted as reinforcing the company's long-term advanced packaging growth trajectory.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.

The consensus estimate has shifted 28.11% due to these changes.

VGM ScoresAt this time, Amkor Technology has a average Growth Score of C, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of B on the value side, putting it in the top 40% for this investment strategy.

Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Amkor Technology has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.

Shares of Toast (TOST -0.06%) have largely underperformed since the company's public market debut in 2021. The restaurant-technology business may be moving into a new era, though, and investors might see Toast reheated soon.

Premium Feature

Moneyball Superscore

81/100

Today's Change

(

-0.06

%) $

-0.02

Current Price

$

35.15

Toast's fundamentals are looking better. The company beat second-quarter expectations, and its earnings per share (EPS) almost doubled year over year. Toast raised its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance for Q3 to $220 million. A slew of analysts increased their price targets on the good news.

The company continues to add new restaurants to its customer base while simultaneously increasing the number of transactions it processes. It's also investing in artificial intelligence (AI) tools that will help customers with order taking and administrative tasks, and generate valuable customer insights. Lastly, Toast expanded its integrations with Alphabet's Google and entered into a new partnership with the Dutch payments company Adyen.

Image source: The Motley Fool.

Investors have been scared off by the consistent insider selling, including by the CEO and chief revenue officer. The company's valuation is still a bit rich in my opinion. Despite the stock declining 15% in the past year and more than 44% since its initial public offering (IPO), the trailing price-to-earnings (P/E) ratio still sits in the mid-40s.

The company is competing with powerhouse Square, which Block owns. Square has a slight advantage in market share, but Toast could gain ground as it focuses on its Google integration and partnerships.

Toast has an expanding platform and customer base; it added 9,500 new net customers in its latest quarter. I'm cautiously optimistic that there is room for this stock to run over the next few years as its metrics continue to improve. Investors will still need a bit of patience and appetite for Toast's volatility, however. Ultimately, I like where Toast is heading.

Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Adyen, Alphabet, Block, and Toast. The Motley Fool has a disclosure policy.

Companies join forces to help professional builders work smarter, build faster, and deliver a better homeowner experience.

, /PRNewswire/ -- Builders FirstSource, Inc. (NYSE: BLDR), a leading provider of building materials and value-added services, and Digs, a leading AI platform for homebuilders and homeowners, today announced a strategic partnership to deliver the next generation of AI-powered workflows and digital infrastructure for professional builders and homeowners.

Under the partnership, Builders FirstSource is the solo lead on Digs' $25.3 million Series A financing and has also entered into a five-year commercial agreement with Digs to accelerate product development, strengthen platform integration, and expand AI capabilities. Through the commercial agreement, the companies will collaborate to strengthen Builders FirstSource's digital ecosystem for residential homebuilders and build out new experiences for homeowners.

"Our customers are looking for seamless technology that helps them operate more efficiently and deliver a better homeowner experience," said Peter Jackson, CEO of Builders FirstSource. "By combining Builders FirstSource's scale, deep customer relationships, product data, and extensive digital ecosystem with Digs' AI platform, we are advancing tools that can simplify workflows, improve productivity, and create a more connected experience across the homebuilding lifecycle, enabling us to serve our customers in new ways at every stage."

The companies intend to leverage Builders FirstSource's comprehensive digital ecosystem and Digs' patented AI platform to better serve homebuilders, including the more than 140,000 customers served by Builders FirstSource today, by helping them eliminate disconnected workflows, reduce manual work, and deliver exceptional homeowner experiences from pre-construction through warranty and beyond.

One Intelligent Platform Across the Entire Build

As part of the partnership, Builders FirstSource and Digs intend to enhance Builders FirstSource's digital ecosystem with Digs' patented AI technology to turn thousands of disconnected construction documents into a single living source of truth, connecting plans, specifications, selections, products, approvals, warranties, conversations, and project history into one intelligent platform.

For builders: Every stakeholder can work from the same trusted information, from estimating and purchasing to construction, design, sales, and homeowner care. For homeowners: Greater transparency during construction and a complete digital twin of their home that continues delivering value long after move-in. The result is faster decisions, less rework, shorter project cycle times, and a better ownership experience.

Helping Builders Work Faster at Every Stage

The partnership accelerates a new generation of AI-powered capabilities to streamline operations and improve both internal workflows and the homeowner experience.

Planned innovations include:

A single source of truth for every project with AI chat, files, e-signatures, QR codes, comments, tasks, and project collaboration. AI-powered diagramming, finish selections, and visual coordination between builders, designers, trades, and homeowners. Consumer-grade client experiences that keep homeowners informed throughout construction while reducing interruptions to project teams. AI-powered homeowner handoff, warranty, and aftercare that extends the builder relationship long after move-in. Integrated into Builders FirstSource's digital ecosystem, these connected workflows will be devised to span estimating, procurement, construction, and ongoing homeownership, helping teams build more homes with greater efficiency and confidence.

Extending the Builder Relationship Beyond Move-In

This intelligent foundation will be designed to enable homeowners to receive personalized maintenance guidance, warranty support, and tailored services for their home, while giving builders a more efficient way to manage aftercare and strengthen long-term customer relationships.

Over time, it opens the door to new services and innovations across the full life of the home.

"Our vision has always been beyond construction software," said Ryan Fink, CEO and Co-founder of Digs. "We're building the AI platform that understands every home. Builders FirstSource brings national reach, industry relationships, product data, and market scale. Together, we're creating something even beyond the next generation of residential construction, we're creating the first scalable true digital twin of the home for homeowners to power new experiences for the life of their home."

About Builders FirstSource

Builders FirstSource (NYSE: BLDR), headquartered in Irving, Texas, is a leading provider of building materials for professional builders in new residential construction and repair and remodeling. We deliver integrated homebuilding solutions by manufacturing, supplying, and installing a full range of structural and related building products. With approximately 565 locations across 43 states, we serve 48 of the top 50 and 91 of the top 100 Core Based Statistical Areas (CBSAs), ensuring broad geographic coverage and enhancing our ability to partner with our customers. Our leading network of strategically located manufacturing facilities produces factory-built roof and floor trusses, wall panels, vinyl windows, custom millwork and trim, manufactured and semi-custom modular homes, as well as engineered wood that we design and cut specifically for each home. We also assemble interior and exterior doors into pre-hung units for easy installation. Additionally, we distribute a wide range of building products, including lumber, sheet goods, windows, doors, millwork, and specialty items. Our services, which vary by market, include professional installation, turnkey framing, and shell construction. Supported by the latest construction innovations and digital solutions, we help drive greater efficiency across homebuilding. Learn more at www.bldr.com.

About Digs

Digs is the leading AI platform for homebuilders and homeowners. Using patented artificial intelligence, Digs transforms construction documents into a single source of truth that helps builders boost productivity, accelerate workflows, improve collaboration, and deliver exceptional homeowner experiences from pre-construction through warranty, aftercare, and beyond. Digs serves builders, contractors, designers, trade partners, vendors, and homeowners across all 50 states.

Forward-Looking Statements

Statements in this news release and the schedules hereto that are not purely historical facts or that necessarily depend upon future events, including statements about the partnership between Builders FirstSource and Digs, the resulting product innovation and the capabilities of Builders FirstSource's and Digs' digital platforms, may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on forward-looking statements. In addition, oral statements made by the Builders FirstSource's directors, officers and employees to the investor and analyst communities, media representatives and others, depending upon their nature, may also constitute forward-looking statements. As with the forward-looking statements included in this release, these forward-looking statements are by nature inherently uncertain, and actual results or events may differ materially as a result of many factors. All forward-looking statements are based upon information available to Builders FirstSource on the date this release was submitted. Builders FirstSource undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements involve risks and uncertainties, many of which are beyond the Builders FirstSource's control or may be currently unknown to the Builders FirstSource, that could cause actual events or results to differ materially from the events or results described in the forward-looking statements; such risks or uncertainties include those related to the partnership between Builders FirstSource and Digs and the ability of the partnership to achieve the anticipated benefits thereof, adoption of the technologies being developed by Builders FirstSource and Digs by homebuilders and homeowners, the ability of Builders FirstSource's growth strategies, including acquisitions, organic growth and digital and technology strategies, including the Builders FirstSource's ability to drive growth by incorporating artificial intelligence and machine learning solutions into its platform, or the dependence of the Builders FirstSource's revenues and operating results on, among other things, the homebuilding industry and, to a lesser extent, repair and remodel activity, which in each case is dependent on economic conditions, including inflation, interest rates, home size and affordability, consumer confidence, labor and supply shortages, tariffs and duties, and also lumber and other commodity prices. The Builders FirstSource may not succeed in addressing these and other risks. Further information regarding factors that could affect our financial and other results can be found in the risk factors section of Builders FirstSource's most recent annual report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") and may also be described from time to time in the other reports Builders FirstSource files with the SEC. Consequently, all forward-looking statements in this release are qualified by the factors, risks and uncertainties contained therein.

SOURCE Digs

It has been about a month since the last earnings report for GE HealthCare Technologies (GEHC - Free Report) . Shares have added about 3.6% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is GE HealthCare due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for GE HealthCare Technologies Inc. before we dive into how investors and analysts have reacted as of late.

GEHC Q2 Earnings & Revenues Beat EstimatesGE HealthCare reported second-quarter 2026 adjusted earnings per share of $1.13, which beat the Zacks Consensus Estimate of $1.04 by 8.7%. The bottom line increased 6.6% year over year, aided by commercial execution, pricing and productivity gains.

GAAP EPS in the quarter was $1.24, up 16.5% from the year-ago level.

GEHC's Revenue Growth Gains MomentumRevenues of $5.29 billion increased 5.7% year over year on a reported basis and 3.5% organically. The top line surpassed the Zacks Consensus Estimate by 0.7%. Revenue growth was led by Pharmaceutical Diagnostics (PDx) and Advanced Imaging Solutions (AIS), along with strength in the United States, EMEA and Rest of World markets. However, growth was partially offset by a decline in the Patient Care Solutions (PCS) segment.

Total company orders increased 11.1% year over year organically. The book-to-bill ratio was 1.15X, indicating rising orders compared to shipments, with backlog reaching a record $23.9 billion. Management cited order growth across every segment, supported by strong commercial execution and adoption of new products.

GE HealthCare’s Q2 Segmental DetailsPharmaceutical Diagnostics revenues increased 15.6% year over year to $843 million. Growth was supported by higher contrast-media volumes, pricing and U.S. radiopharmaceutical demand. Segment EBIT was $250 million, up 16.9% year over year.

Advanced Imaging Solutions revenues increased 7.9% year over year to $3.77 billion. Growth was supported by CardioVascular and Interventional Solutions, computed tomography and Molecular Imaging. Segment EBIT was $525 million, up 15.4% year over year.

Patient Care Solutions revenues declined 13.3% year over year to $675 million. Management attributed the decline primarily to operational and fulfillment challenges, despite strong first-half orders that indicated healthy customer demand.

GEHC's Margin and Cash Flow ImproveNet income margin expanded 90 basis points to 10.6%. However, net income margin was negatively impacted due to PCS weakness and inflation in memory chips, oil and freight costs.

Cumulative cash flow from operating activities at the end of the second quarter was $458 million compared with $344 million a year ago.

GE HealthCare’s Financial PositionGEHC exited the second quarter with cash, cash equivalents and restricted cash of $2.11 billion compared with $2.28 billion in the previous quarter.

Total assets increased to $37.25 billion from $37.12 billion on a sequential basis.

GE HealthCare Reaffirms 2026 GuidanceGE HealthCare reaffirmed its guidance for 2026.

The company still expects organic revenue growth of 3-4% in 2026. It anticipates adjusted earnings per share to be in the range of $4.80-$5.00, implying 4.6%-9.0% year-over-year growth, as expected previously.

Management anticipates approximately $250 million of inflation associated with memory chips, oil and freight and other components, but expects pricing and cost actions to offset more than half of that impact.

How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.

VGM ScoresCurrently, GE HealthCare has a subpar Growth Score of D, a grade with the same score on the momentum front. However, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, GE HealthCare has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry PlayerGE HealthCare is part of the Zacks Medical - Products industry. Over the past month, Abbott (ABT - Free Report) , a stock from the same industry, has gained 5.7%. The company reported its results for the quarter ended June 2026 more than a month ago.

Abbott reported revenues of $12.59 billion in the last reported quarter, representing a year-over-year change of +13%. EPS of $1.31 for the same period compares with $1.26 a year ago.

Abbott is expected to post earnings of $1.43 per share for the current quarter, representing a year-over-year change of +10%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.2%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Abbott. Also, the stock has a VGM Score of B.

Bank of Nova Scotia bought a new stake in shares of Diamondback Energy, Inc. (NASDAQ:FANG – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 28,279 shares of the oil and natural gas company’s stock, valued at approximately $4,971,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Compass Financial Management LLC acquired a new stake in Diamondback Energy in the second quarter valued at approximately $63,000. Elevation Point Wealth Partners LLC acquired a new position in shares of Diamondback Energy during the 2nd quarter worth $1,493,000. Daiichi Life Insurance Co. Ltd. acquired a new position in shares of Diamondback Energy during the 2nd quarter worth $1,243,000. Commerce Bank bought a new position in shares of Diamondback Energy during the 2nd quarter valued at $14,457,000. Finally, GQG Partners LLC bought a new position in shares of Diamondback Energy during the 2nd quarter valued at $103,192,000. 90.01% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets In other Diamondback Energy news, EVP Matt Zmigrosky sold 5,000 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $200.54, for a total value of $1,002,700.00. Following the completion of the transaction, the executive vice president directly owned 46,392 shares of the company’s stock, valued at approximately $9,303,451.68. The trade was a 9.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Mark Lawrence Plaumann sold 500 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $196.50, for a total value of $98,250.00. Following the sale, the director owned 13,437 shares of the company’s stock, valued at approximately $2,640,370.50. The trade was a 3.59% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 129,167 shares of company stock worth $24,714,309. 0.64% of the stock is owned by company insiders.

Diamondback Energy Trading Down 2.8% Diamondback Energy stock opened at $199.89 on Wednesday. The business has a 50 day moving average price of $192.34 and a two-hundred day moving average price of $189.96. The company has a quick ratio of 0.45, a current ratio of 0.47 and a debt-to-equity ratio of 0.25. The stock has a market cap of $55.97 billion, a price-to-earnings ratio of 38.96 and a beta of 0.43. Diamondback Energy, Inc. has a 12 month low of $134.30 and a 12 month high of $216.90. Diamondback Energy (NASDAQ:FANG – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The oil and natural gas company reported $6.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.08 by $0.40. Diamondback Energy had a net margin of 8.58% and a return on equity of 10.10%. The firm had revenue of $5.56 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same quarter in the previous year, the firm posted $2.38 EPS. The business’s revenue for the quarter was up 51.2% on a year-over-year basis. As a group, equities analysts forecast that Diamondback Energy, Inc. will post 20.13 EPS for the current year.

Diamondback Energy Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Thursday, August 13th were given a $1.10 dividend. The ex-dividend date was Thursday, August 13th. This represents a $4.40 annualized dividend and a yield of 2.2%. Diamondback Energy’s payout ratio is presently 85.77%.

Analyst Upgrades and Downgrades Several research firms have recently issued reports on FANG. Roth Capital set a $212.00 price target on Diamondback Energy and gave the stock a “buy” rating in a research note on Monday, June 22nd. Wells Fargo & Company raised their price objective on Diamondback Energy from $262.00 to $263.00 and gave the company an “overweight” rating in a research note on Wednesday, August 5th. Truist Financial boosted their target price on Diamondback Energy from $220.00 to $224.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $248.00 target price on shares of Diamondback Energy in a research report on Friday, July 31st. Finally, Sanford C. Bernstein increased their price target on Diamondback Energy from $237.00 to $241.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Four investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $222.21.

Check Out Our Latest Analysis on Diamondback Energy

Diamondback Energy Profile (Free Report)

Diamondback Energy, Inc (NASDAQ: FANG) is an independent oil and natural gas company focused on the development, exploration and production of unconventional resources in the Permian Basin. Headquartered in Midland, Texas, the company concentrates its operations in the core Midland and Delaware sub‑basins of West Texas and southeastern New Mexico, where it pursues contiguous acreage positions to support repeatable drilling programs.

Diamondback’s activities span the upstream value chain, including leasehold acquisition, well planning, drilling, completion and production optimization.

Further Reading Five stocks we like better than Diamondback Energy Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for Diamondback Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diamondback Energy and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Datadog saw 58% of customers use at least four products, while 37% used six or more as of June 2026.A major online media company signed a multiyear Datadog deal worth more than $30 million in contract value.Datadog's Real User Monitoring topped $200 million in ARR and grew more than 50% year over year. Datadog’s (DDOG - Free Report) multi-product strategy is gaining traction; a growing number of customers are adopting its additional products, thereby creating further opportunities to increase revenues from existing customers. As of June 30, 2026, 58% of customers used at least four Datadog products, up from 52% a year earlier, while the share using six or more rose to 37% from 29%; those using 10 or more nearly doubled to 13% from 7%. Datadog's land-and-expand model supports this expansion, as management notes that the company typically lands customers with two or more products and then expands from there.

The strategy is also translating into larger customer relationships. A South American bank consolidated onto 11 Datadog products and is adding security offerings, while a Fortune 100 health insurer is expanding to 19 products. A major online media company signed a multiyear deal worth more than $30 million in total contract value after standardizing on Datadog and adopting products beyond core observability, including Product Analytics, CI Visibility, Data Observability and Cloud Cost Management.

Datadog's expanding product footprint is creating more opportunities to deepen existing customer relationships. RUM, or Real User Monitoring, surpassed $200 million in ARR and grew more than 50% year over year, with customers increasingly using it alongside Product Analytics. Together, rising multi-product adoption, larger platform deployments and growth in newer offerings could help Datadog generate more revenues from its existing customer base.

The Zacks Consensus Estimate projects year-over-year total revenue growth of 28.9% in 2026, highlighting the company's growth potential.

DDOG Faces Stiff Competition From Dynatrace & CiscoDynatrace (DT - Free Report) and Cisco (CSCO - Free Report) are broadening their unified platforms to encourage tool consolidation and deeper customer adoption, intensifying competition for the same expansion opportunities underpinning DDOG’s multi-product strategy.

Dynatrace is competing with DDOG through an end-to-end observability platform designed to drive broader adoption and consolidation. DT says customers often expand quickly, with significant cross-sell and upsell opportunities, while log-management growth and AI observability create additional consumption. DT’s 110% NRR reinforces the expansion opportunity.

Cisco challenges DDOG through a broader technology portfolio spanning networking, security and observability. CSCO says more than half of customers buy both campus and data-center networking, while Splunk integration is generating whole-portfolio agreements. Cisco’s unified cloud control further strengthens cross-product adoption by providing a single management plane across various products.

DDOG’s Share Price Performance, Valuation & EstimatesShares of DDOG have surged 66.1% year to date, outperforming the broader Zacks Computer and Technology sector's growth of 15.7%.

DDOG’s YTD Price Performance
Image Source: Zacks Investment Research

From a valuation perspective, DDOG appears overvalued, trading at a forward price-to-sales ratio of 15.93, significantly higher than the Internet – Software industry average of 3.93. The company carries a Value Score of F.

DDOG’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for DDOG’s 2026 earnings is currently pegged at $2.52 per share, an increase of 4.6% over the past 30 days. The company reported earnings of $2.05 per share in 2025.

Image Source: Zacks Investment Research

Datadog stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways ODFL supports shareholders through dividends and buybacks while maintaining a low debt profile. Pricing discipline adds strength, but weak freight demand weighs on the company. ODFL shares have gained so far this year, but underperform its industry and peers like JBHT and KNX. Old Dominion Freight Line, Inc. (ODFL - Free Report) is currently mired in multiple tailwinds, which, we believe, have made it an impressive investment option. The positive sentiment surrounding Old Dominion stock is evident from the fact that the Zacks Consensus Estimate for the third quarter of 2026 and the fourth quarter of 2026 earnings has been revised upward in the past 60 days. The consensus mark for 2026 and 2027 earnings has also been projected upward in the past 60 days.

The favorable estimate revisions indicate brokers’ lack of confidence in the stock.

Image Source: Zacks Investment Research

Given this backdrop, the question now arises whether it is worth buying, holding, or selling the Old Dominion stock at current prices. Let us delve deeper to find out.

Factors Working in Favor of ODFL StockODFL’s disciplined approach to pricing is highly commendable. The company’s cost-based approach to pricing enables it to retain customers and supports tonnage even in times of weak demand. This is borne out by the LTL revenue per hundredweight indicator (a commonly used indicator for general pricing trends in the industry), which for ODFL improved 2.4% in 2024 despite demand weakness. The same metric improved 3.9% year over year in 2025.

Old Dominion’s solid balance sheet increases financial flexibility. The company ended second-quarter 2026 with cash and equivalents of $283.9 million, higher than the current debt level of $20 million. This implies that the company has sufficient cash to meet its current debt obligations.

A solid balance sheet enables the company to reward shareholders with dividends and share repurchases. As a reflection of its shareholder-friendly stance, ODFL paid dividends of $175.1 million and repurchased shares worth $453.6 million in 2023, despite the weakness pertaining to freight demand. During 2024, ODFL paid out dividends worth $223.6 million and repurchased shares worth $967.3 million.

During 2025, ODFL paid out dividends worth $235.6 million and repurchased shares worth $730.3 million. For the first six months of this year, ODFL repurchased shares worth $239.7 million and paid $120.7 million in cash dividends.

ODFL Stock’s Price PerformanceShares of ODFL have gained 28.5% so far this year, underperforming the transportation-truck industry’s 35.1% surge, as well as that of other industry players, J.B. Hunt Transport Services (JBHT - Free Report) and Knight-Swift Transportation Holdings Inc. (KNX - Free Report) within the same time frame.

ODFL Stock’s YTD Price Comparison Image Source: Zacks Investment Research

Unattractive Valuation Picture for ODFL StockOld Dominion looks expensive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/E-F12M), ODFL is trading at a premium compared to the industry.

The stock has a forward 12-month P/E-F12M of 31.93X compared with 28.5X for the industry over the past five years. The company’s forward 12-month P/E-F12M ratio is also above the median level of 29.91X over the past five years. These factors indicate that the stock’s valuation is unattractive. ODFL has a Value Score of F.

ODFL P/E Ratio (Forward 12 Months) Vs. Industry Image Source: Zacks Investment Research

Time to Buy ODFL StockOld Dominion’s cost-based approach to pricing enables the company to retain customers and supports tonnage even in times of weak demand. ODFL’s solid balance sheet allows it to reward shareholders through dividends and share buybacks are impressive. Such shareholder-friendly moves boost investor confidence and positively impact the company's bottom line. We believe that the positives surrounding the stock (as highlighted throughout the write-up) outweigh the concerns regarding revenue weakness as geopolitical uncertainty and high inflation continue to hurt consumer sentiment and growth expectations. The increase in inflation in the past few months shows that we are not yet out of the woods as far as inflation is concerned. Driver shortages continue to bother the trucking industry and its players.

We, therefore, suggest investors add Old Dominion stock to their portfolios for healthy returns. The company’s Zacks Rank #2 (Buy) further supports our thesis. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Atlassian's Rovo is used by more than 80% of the Fortune 500, with usage up 50% sequentially.Rovo users are growing ARR at more than twice the rate of customers that do not use Rovo.Atlassian can drive more seats and revenues through Rovo upgrades, Teamwork Collection and cross-selling. Atlassian Corporation (TEAM - Free Report) is seeing strong adoption of Rovo, which could help drive customer expansion and ARR growth. In the fourth quarter of fiscal 2026, subscription ARR increased 23% year over year. Rovo is now used by more than 80% of the Fortune 500, while Rovo-assisted actions increased 50% sequentially. Further, customers using Rovo are growing their ARR at more than twice the rate of customers that do not use Rovo. The strong adoption and higher usage suggest that Rovo is becoming an important part of Atlassian's efforts to increase spending within its existing customer base.

Rovo is also helping Atlassian increase revenues from existing customers. As Rovo usage rises, customers are buying more Rovo credits. Teamwork Collection offers about 10 times more Rovo credits and is encouraging customers to upgrade and add seats. Atlassian said these upgrades are helping increase average revenue per user. Teamwork Collection customers also have 4-5 times more paid seats per instance than stand-alone Jira or Confluence customers. This gives Atlassian an opportunity to convert higher Rovo usage into more seats, broader product adoption and higher revenue per customer.

Higher AI adoption is also helping Atlassian's cloud business. Cloud revenues increased 31% year over year in the fourth quarter. Management said cross-selling and seat expansion were the main drivers behind the strong cloud momentum. The company also saw strong adoption of Teamwork Collection and Service Collection, while customers continued to add Jira and Confluence seats. As customers use AI across more teams and workflows, Atlassian could have more opportunities to expand its platform within large enterprise accounts.

Atlassian has further room to grow within its existing customer base. Management estimates about $14 billion of opportunity from existing customers without changing products or pricing. These factors suggest that if Rovo usage continues to increase and drives more upgrades, seats and cross-selling, it could help Atlassian support ARR growth. The Zacks Consensus Estimate for TEAM's fiscal 2027 and 2028 revenues indicates year-over-year growth of 13% and 14.8%, respectively.

Atlassian Faces Stiff CompetitionAtlassian faces stiff competition from other key players in the cloud software industry such as Salesforce (CRM - Free Report) and ServiceNow (NOW - Free Report) .

Salesforce competes with Atlassian through offerings such as Agentforce, Data Cloud and Slack, which together create a unified ecosystem that connects customer data with integrated AI across systems, apps and devices. In the first quarter of fiscal 2027, Agentforce’s ARR surpassed $1 billion, up in triple digits year over year. Salesforce expects this momentum to continue in fiscal 2027, on the back of robust customer demand for its agentic offerings.

ServiceNow is seeing strong demand for its Agentic AI products as enterprises look to automate more work and improve productivity. The company is expanding AI across IT, customer service, employee service and security. Management said customers now want AI that can complete tasks and deliver clear business value instead of simply assisting employees. This is helping drive adoption of the company's AI offerings. AI annual contract value (ACV) crossed $1 billion during the second quarter of 2026, and ServiceNow expects AI ACV to exceed $1.5 billion by the end of 2026.

TEAM’s Price Performance, Valuation & EstimatesTEAM shares have jumped 5.6% in the year-to-date period against the Zacks Internet - Software industry’s decline of 4.3%.

TEAM YTD Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, Atlassian trades at a forward 12-month price-to-sales ratio of 5.73X compared with the industry’s 3.93X. TEAM has a Value Score of F.

TEAM’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for TEAM's fiscal 2027 earnings is pegged at $5.52 per share, revised down by 6.6% over the past 30 days, indicating a year-over year decline of 5.6%.

Image Source: Zacks Investment Research

TEAM stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Bank of Nova Scotia acquired a new stake in shares of Teledyne Technologies Incorporated (NYSE:TDY – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,509 shares of the scientific and technical instruments company’s stock, valued at approximately $3,675,000.

Several other institutional investors have also modified their holdings of TDY. Elevation Point Wealth Partners LLC purchased a new stake in Teledyne Technologies during the 2nd quarter valued at $878,000. Daiichi Life Insurance Co. Ltd. bought a new stake in Teledyne Technologies in the second quarter worth $9,773,000. Commerce Bank purchased a new position in Teledyne Technologies during the second quarter worth $1,216,000. Northwestern Mutual Wealth Management Co. purchased a new position in Teledyne Technologies during the second quarter worth $351,000. Finally, Quantbot Technologies LP bought a new position in Teledyne Technologies during the second quarter valued at $115,000. 91.58% of the stock is owned by institutional investors.

Analysts Set New Price Targets Several equities research analysts have recently issued reports on TDY shares. Barclays raised their target price on shares of Teledyne Technologies from $614.00 to $640.00 and gave the stock an “equal weight” rating in a report on Friday, July 24th. Weiss Ratings reiterated a “buy (b)” rating on shares of Teledyne Technologies in a report on Wednesday, August 19th. Jefferies Financial Group raised shares of Teledyne Technologies to a “strong-buy” rating in a research report on Wednesday, June 10th. Stifel Nicolaus raised their price objective on shares of Teledyne Technologies from $750.00 to $775.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Finally, Citigroup boosted their target price on Teledyne Technologies from $677.00 to $680.00 and gave the company a “neutral” rating in a research report on Wednesday, July 1st. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $721.67.

Get Our Latest Stock Report on Teledyne Technologies Teledyne Technologies Trading Up 0.3% TDY stock opened at $627.39 on Wednesday. Teledyne Technologies Incorporated has a 12 month low of $483.02 and a 12 month high of $697.67. The firm’s 50-day moving average is $647.66 and its 200 day moving average is $641.59. The company has a market capitalization of $29.09 billion, a PE ratio of 30.29, a P/E/G ratio of 2.72 and a beta of 0.92. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.18 and a quick ratio of 1.39.

Teledyne Technologies (NYSE:TDY – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The scientific and technical instruments company reported $6.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.79 by $0.49. The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Teledyne Technologies had a net margin of 15.29% and a return on equity of 10.56%. The firm’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.20 EPS. Teledyne Technologies has set its FY 2026 guidance at 24.450-24.650 EPS and its Q3 2026 guidance at 6.050-6.150 EPS. On average, research analysts anticipate that Teledyne Technologies Incorporated will post 24.69 EPS for the current year.

Insider Activity In related news, Director Simon M. Lorne sold 6,449 shares of the stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $680.34, for a total value of $4,387,512.66. Following the transaction, the director owned 55,783 shares of the company’s stock, valued at $37,951,406.22. This represents a 10.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.36% of the company’s stock.

(Free Report)

Teledyne Technologies (NYSE: TDY), headquartered in Thousand Oaks, California, is a diversified industrial technology company that designs, manufactures and supports sophisticated electronic systems, instruments and imaging products. Founded in 1960 by Henry Singleton and George Kozmetsky, Teledyne has grown into a multinational provider of high-performance equipment and software for commercial, scientific and government customers. Its offerings are used in markets that include aerospace and defense, marine, industrial manufacturing, environmental monitoring and scientific research.

The company operates through businesses that develop precision instrumentation, digital imaging products, engineered systems and aerospace and defense electronics.

Featured Articles Five stocks we like better than Teledyne Technologies Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for Teledyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teledyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Toro is leveraging its AMP productivity program to boost efficiency and generate cost savings.Toro is investing in AI, autonomous solutions and smart-connected products to drive innovation.Toro is expanding underground construction, parts and services while pursuing disciplined acquisitions. The Toro Company (TTC - Free Report) is likely to post a year-over-year increase in its top and bottom lines when it reports third-quarter fiscal 2026 results on Sept. 3, before market open. The Zacks Consensus Estimate for quarterly earnings is pegged at $1.30 per share, indicating an increase of 4.8% from the prior-year number. The consensus estimate for earnings has been stable in the past 30 days.

The consensus estimate for quarterly revenues is pegged at $1.2 billion, indicating a rise of 5.2% year over year.

In the last reported quarter, the company delivered an earnings surprise of 6.7%. It has a trailing four-quarter earnings surprise of 7%, on average.

Factors Likely to Have Impacted TTC’s Q3 EarningsToro’s quarterly results are expected to reflect benefits from the ongoing execution of its strategic efforts. It is focused on driving growth through its AMP productivity program, which leverages lean principles, Kaizen events and continuous improvements to generate cost savings and improve operational efficiency. In addition, the company is seeing strength across its Toro, Exmark and Ventrac brands.

The company is also streamlining its manufacturing footprint, workforce and product portfolio to strengthen margins and offset inflationary and tariff pressures. Toro is increasing investments in electrification, smart-connected products, autonomous solutions, Artificial Intelligence and advanced manufacturing technologies to enhance product innovation and efficiency.

The company is expanding its underground construction business through strong demand for Ditch Witch equipment and the integration of Tornado, while also seeking to increase parts and service penetration. In golf, Toro is advancing autonomous solutions to help customers improve productivity and address labor constraints. The company also remains open to disciplined acquisitions, particularly in the Professional segment, where it can leverage existing capabilities and technology to enter adjacent markets. All the aforesaid factors are likely to boost TTC’s results in the quarter under review.

The Zacks Consensus Estimate for Professional and Residential segments’ sales is pegged at $983 million and $197 million, respectively, showing year-over-year increases of 5.6% and 2.1%.

On the flip side, Toro continues to face headwinds, including higher material and fuel costs, tariff expenses, inflation and challenging consumer confidence. Residential demand remains pressured by cautious consumers, with some homeowners trading down to lower-priced products, while weakness in European residential markets is also weighing on international performance.

What the Zacks Model Unveils for TTCOur proven model does not conclusively predict an earnings beat for Toro this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.

Toro has an Earnings ESP of 0.00% and a Zacks Rank of 3. You can uncover the best stocks before they're reported with our Earnings ESP Filter.

TTC’s Valuation PictureFrom a valuation perspective, Toro’s shares are trading at a premium relative to the industry benchmarks. The stock has a forward 12-month price-to-earnings ratio of 20.29X, above the five-year median of 19.26X and the Tools - Handheld industry’s average of 19.57X.

The recent market movements show that Toro shares have gained 0.9% in the past six months compared with the industry's 3% growth.

Stocks With the Favorable CombinationHere are some companies, which according to our model, have the right combination of elements to beat on earnings this reporting cycle.

Boyd Gaming Corporation (BYD - Free Report) currently has an Earnings ESP of +0.43% and a Zacks Rank of 3. BYD is likely to register a top-line decrease when it reports third-quarter 2026 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1 billion, indicating a 0.04% drop from the figure reported in the year-ago quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.

The consensus estimate for BYD’s third-quarter earnings is pegged at $1.74 a share, implying a 1.2% rise from the year-earlier quarter. BYD has a trailing four-quarter average earnings surprise of 5.4%.

Cintas Corporation (CTAS - Free Report) currently has an Earnings ESP of +0.09% and a Zacks Rank of 3. The Zacks Consensus Estimate for first-quarter fiscal 2027 earnings per share is pegged at $1.35, which implies 12.5% year-over-year growth.

The consensus estimate for quarterly revenues is pegged at nearly $3 billion, implying 9.2% year-over-year growth. CTAS has a trailing four-quarter earnings surprise of 1.8%, on average.

Carnival (CCL - Free Report) currently has an Earnings ESP of +0.32% and a Zacks Rank of 3. CCL is likely to register growth in its top line when it reports third-quarter fiscal 2026 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $8.4 billion, indicating a 2.6% increase from the figure in the year-ago quarter.

 The consensus estimate for CCL’s earnings is pegged at $1.36 per share, implying a 4.9% drop from the year-ago quarter’s actual. CCL displays a trailing four-quarter earnings surprise of 18.2%, on average.

-Data presented in a late-breaking presentation at the European Society of Cardiology (ESC) Congress 2026-

-Phase 1a clinical data for CTX310® continued to demonstrate robust, dose-dependent reductions in circulating ANGPTL3 with a mean reduction from baseline of 79% (maximum 89%), a mean reduction in triglycerides (TG) of 48% (maximum 78%), and a mean reduction of low-density lipoprotein (LDL) of 53% (maximum 84%) at the highest dose-

-CTX310 was well tolerated with no treatment-related serious adverse events, no ≥Grade 3 changes in liver transaminases, and no additional treatment-related adverse events since the previous update-

-Findings simultaneously published in The New England Journal of Medicine entitled “Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310”-

ZUG, Switzerland and BOSTON, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today presented durability data from its Phase 1a clinical trial evaluating CTX310®, an investigational, in vivo CRISPR/Cas9 gene editing therapy targeting ANGPTL3. A single-course treatment with CTX310 produced deep and durable reductions in circulating ANGPTL3, triglycerides (TG), and low-density lipoprotein (LDL) that were sustained through one year of follow-up. At the highest dose, mean reductions from baseline were 79% (maximum 89%) for ANGPTL3, 48% (maximum 78%) for TG, and 53% (maximum 84%) for LDL. These extended follow-up data demonstrate the durability of CTX310's effect and support its potential to deliver long-lasting lipid lowering after a single intravenous (IV) infusion.

These data were presented today during a late breaking session at the European Society of Cardiology (ESC) Congress 2026 and extend the Phase 1 results previously presented. The data were also published today in The New England Journal of Medicine (NEJM) in a peer reviewed article entitled "Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310." CRISPR Therapeutics is advancing CTX310 in a Phase 1b clinical trial, with U.S. and ex-U.S. trials ongoing, and expects to provide an additional update on the CTX310 program in the second half of 2026.

"These durability data mark an important next step for the CTX310 program and for the field of in vivo gene editing," said Naimish Patel, M.D., Chief Medical Officer, CRISPR Therapeutics. "Evidence that a single dose can produce lasting lipid lowering is central to our goal of developing one-time treatments for cardiometabolic diseases. These results provide strong support for continued advancement of CTX310 and our broader cardiovascular gene editing portfolio, and we look forward to sharing new data from the severe hypertriglyceridemia cohort of the CTX310 Phase 1b trial in the second half of this year."

"For patients at high cardiovascular risk, the biggest challenge is often not starting therapy but staying on it, since daily medications require lifelong adherence that many patients are unable to maintain," said Luke Laffin, M.D., principal investigator and Medical Director of the Cleveland Clinic Coordinating Center for Clinical Research. "A single infusion producing durable reductions at one-year is an encouraging signal that a one-time approach could help close that adherence gap."

"What is compelling about this update is that the reductions in ANGPTL3, triglycerides, and LDL from a single infusion have persisted out to one-year, suggesting a sustained biological effect," said Steven E. Nissen, M.D., senior author of the study and Chief Academic Officer at the Cleveland Clinic Heart, Vascular and Thoracic Institute. "A one-time treatment with this degree of durability could represent a meaningful advance in how we manage lifelong lipid disorders."

Phase 1a Clinical Trial Design

The Phase 1a portion of the study was an open label, dose-escalation trial evaluating single-course IV doses of CTX310 ranging from 0.1 to 0.8 mg/kg (lean body weight) targeting ANGPTL3 in four patient groups: homozygous familial hypercholesterolemia (HoFH), severe hypertriglyceridemia (sHTG), heterozygous familial hypercholesterolemia (HeFH), or mixed dyslipidemias (elevated TG and LDL). Eligible participants had uncontrolled TG levels >150 mg/dL and/or LDL cholesterol >100 mg/dL (or >70 mg/dL for those with established ASCVD) despite background standard of care per local guidelines.

The majority of participants were receiving statins and/or ezetimibe, while 40% were taking PCSK9 inhibitors. The trial was designed to evaluate safety and tolerability as primary endpoints, with changes in circulating ANGPTL3 protein, TG, and LDL as secondary endpoints.  

Safety and Tolerability

Single-course ascending doses of CTX310 were administered to 15 participants across sequential cohorts, and all participants completed at least one-year of follow-up as of the data cutoff. CTX310 was generally well tolerated, and no dose-limiting toxicities or serious adverse events related to treatment. Adverse events were generally mild to moderate.

As previously reported in Laffin et al. (2025), one participant experienced an allergic reaction that resolved the following day with supportive care. Infusion-related reactions occurred in three participants (two at 0.6 mg/kg and one at 0.8 mg/kg dose), all Grade 2. All events resolved, and all participants completed their infusions. Beyond the transient aminotransferases elevation previously reported in one participant shortly after treatment, there were no liver function test elevations throughout the remainder of the trial.

The safety events described above were previously reported in Laffin et al. (New England Journal of Medicine, 2025) and reflect the initial treatment period of the Phase 1a clinical trial. No new treatment-related safety events were observed during extended follow-up.

Efficacy Highlights

These new results build upon previously disclosed clinical data from 15 participants across four sequential cohorts, corresponding to lean body weight-based doses of DL1 [0.1 mg/kg], DL2 [0.3 mg/kg], DL3 [0.6 mg/kg], DL3.5 [0.7 mg/kg] and DL4 [0.8 mg/kg]. All participants had at least one-year of follow-up.

Dose dependent reductions in circulating ANGPTL3 protein were sustained through one-year following CTX310 infusion.Among participants treated at 0.8 mg/kg, ANGPTL3 reductions of up to 89% were observed, with a mean reduction of 79% at one-year following CTX310 infusion. Next Steps

The Phase 1b portion of the trial examines a fixed flat dose regimen of CTX310 equivalent to the most efficacious dose in Phase 1a (0.8mg/kg). CRISPR Therapeutics continues to anticipate sharing an update from the CTX310 Phase 1b clinical trial in the second half of 2026, focused on severe hypertriglyceridemia patients.

About In Vivo Liver Editing Programs

CRISPR Therapeutics has established a proprietary lipid nanoparticle (LNP) delivery platform to enable gene editing in the liver using both CRISPR/Cas9 and its novel, proprietary SyNTase™ editing technology. The Company's in vivo portfolio includes three cardiovascular programs: CTX310, targeting angiopoietin-related protein 3 (ANGPTL3), in development for heterozygous and homozygous familial hypercholesterolemia, mixed dyslipidemias, and severe hypertriglyceridemia; CTX340™, targeting angiotensinogen (AGT), in development for refractory hypertension; and CTX321™, targeting LPA, in development for patients with elevated lipoprotein(a) [Lp(a)]. In addition, the Company's disclosed development candidates also include CTX460™, targeting SERPINA1 using SyNTase editing, for the treatment of alpha-1 antitrypsin deficiency (AATD).

About CRISPR Therapeutics

CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases. Founded over a decade ago as an early pioneer in CRISPR/Cas9 gene editing, the Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. Today, CRISPR Therapeutics is advancing a broad, diversified pipeline spanning hemoglobinopathies, cardiovascular disease, autoimmune disease, oncology, regenerative medicine and rare diseases. The Company is also expanding its gene editing toolkit through SyNTase™ editing, its novel, proprietary platform designed to enable precise, efficient, and scalable gene correction. To accelerate its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California. To learn more, visit www.crisprtx.com.

CRISPR THERAPEUTICS® standard character mark and design logo, CTX310®, CTX321™, CTX340™, CTX460™ and SyNTase™ are trademarks and registered trademarks of CRISPR Therapeutics AG. All other trademarks and registered trademarks are the property of their respective owners.

Reference

Laffin L, et al. Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3. The New England Journal of Medicine. 2025.
CRISPR Special Note Regarding Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding any or all of the following: (i) CRISPR Therapeutics preclinical studies, clinical trials and pipeline products and programs, including, without limitation, manufacturing capabilities, status of such studies and trials, potential expansion into new indications and expectations regarding data, safety and efficacy generally; (ii) data included in the above-described oral presentation and any associated abstracts or posters, data included in the above-described article in The New England Journal of Medicine, as well as the ability to use data from ongoing and planned clinical trials for the design and initiation of further clinical trials; and (iii) the therapeutic value, development, and commercial potential of gene editing technologies and therapies, including CRISPR/Cas9 and SyNTase, as well as other technologies. Risks that contribute to the uncertain nature of the forward-looking statements include, without limitation, the risks and uncertainties discussed under the heading “Risk Factors” in CRISPR Therapeutics most recent annual report on Form 10-K and in any other subsequent filings made by CRISPR Therapeutics with the U.S. Securities and Exchange Commission. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by law.

Investor Contact: 
+1-617-307-7503 
[email protected]

Media Contact: 
+1-617-315-4493 
[email protected]

Bank of Nova Scotia purchased a new position in shares of ITT Inc. (NYSE:ITT – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 28,304 shares of the conglomerate’s stock, valued at approximately $5,597,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in ITT in the 2nd quarter valued at about $1,715,593,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of ITT by 55,929.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,518,405 shares of the conglomerate’s stock valued at $263,458,000 after acquiring an additional 1,515,695 shares during the last quarter. Findlay Park Partners LLP purchased a new position in shares of ITT during the 2nd quarter worth about $276,395,000. Norges Bank acquired a new stake in shares of ITT in the fourth quarter worth approximately $194,884,000. Finally, Vanguard Group Inc. boosted its position in shares of ITT by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 8,460,467 shares of the conglomerate’s stock worth $1,467,976,000 after acquiring an additional 620,217 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Insiders Place Their Bets In other news, CAO Mesa Graziano Cheryl De sold 700 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $214.54, for a total transaction of $150,178.00. Following the completion of the transaction, the chief accounting officer owned 7,159 shares of the company’s stock, valued at approximately $1,535,891.86. The trade was a 8.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.88% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades A number of research firms recently issued reports on ITT. DA Davidson increased their target price on shares of ITT from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. KeyCorp lifted their price target on shares of ITT from $250.00 to $263.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Weiss Ratings downgraded shares of ITT from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday. Robert W. Baird set a $246.00 price objective on shares of ITT in a research report on Thursday, May 7th. Finally, Citigroup raised their target price on shares of ITT from $254.00 to $267.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Ten research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, ITT currently has a consensus rating of “Moderate Buy” and an average price target of $241.08. Get Our Latest Analysis on ITT

ITT Trading Up 0.5% NYSE:ITT opened at $205.96 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 1.26 and a debt-to-equity ratio of 0.60. The business’s 50 day moving average is $199.45 and its two-hundred day moving average is $199.62. ITT Inc. has a 52 week low of $166.96 and a 52 week high of $230.32. The company has a market cap of $18.41 billion, a PE ratio of 40.38, a P/E/G ratio of 1.68 and a beta of 1.27.

ITT (NYSE:ITT – Get Free Report) last released its earnings results on Thursday, August 6th. The conglomerate reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.16. The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.39 billion. ITT had a net margin of 8.90% and a return on equity of 15.90%. The firm’s revenue for the quarter was up 51.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.64 earnings per share. ITT has set its FY 2026 guidance at 8.120-8.320 EPS. On average, analysts predict that ITT Inc. will post 8.25 EPS for the current year.

ITT Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 5th. Investors of record on Tuesday, September 8th will be paid a dividend of $0.386 per share. This represents a $1.54 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 8th. ITT’s dividend payout ratio is presently 30.20%.

ITT Company Profile (Free Report)

ITT Inc is a diversified industrial manufacturing company that designs, manufactures and services mission-critical components and systems for global markets. Its engineered solutions support applications in aerospace, defense, transportation, energy and industrial automation. The company focuses on delivering high-performance products that enable reliable fluid handling, precision motion control and robust connectivity in demanding environments.

The company’s operations are organized into three segments: Motion Technologies, which provides precision components and aftermarket repair services for aircraft engines and industrial turbines; Connect & Control Technologies, which offers specialty valves, couplings, seals and proximity sensors for fuel, hydraulics and environmental control systems; and Fluid & Motion Control, which delivers pumps, heat exchangers and fluid management solutions for oil and gas, chemical processing and power generation.

Recommended Stories Five stocks we like better than ITT Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for ITT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITT and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Quanta's backlog reached $53.4B, supported by utility generation, transmission and technology load centers.PWR's four acquisitions are expected to add $1.2-$1.4B in 2026 revenues and $120-$140M in EBITDA.Quanta self-performs 80-85% of its work, strengthening its position in the AI-driven infrastructure buildout. Quanta Services, Inc. (PWR - Free Report) is emerging as a key beneficiary of the massive infrastructure buildout required to support Artificial Intelligence (AI). While AI's impact is often associated with chips and data centers, the rapid expansion of technology load centers is creating an equally important need for power generation, transmission and grid infrastructure — areas where Quanta has significant expertise.

The company's second-quarter 2026 performance highlighted this opportunity. Management reported strong double-digit growth in revenues, adjusted EBITDA and adjusted EPS, alongside a record backlog of roughly $53 billion. Importantly, management said larger programs across utility generation and technology load centers remain ahead, suggesting that current demand could represent only the early stages of a much broader investment cycle.

PWR is also expanding its capabilities to capture more of this opportunity. The acquisitions of Phalcon, Enerfab, Percheron and PSD strengthen its electrical, mechanical, civil and fabrication capabilities while enhancing its position in technology and load centers. Collectively, the acquisitions are expected to contribute $1.2-$1.4 billion of 2026 revenues and $120-$140 million of adjusted EBITDA. Its new joint venture with Hyosung HICO adds another strategic layer by expanding domestic production of high-voltage circuit breakers for utility, industrial and technology load-center markets. The initiative addresses critical supply-chain requirements amid rising electricity demand from data centers, electrification and grid modernization.

Quanta's ability to self-perform 80-85% of its work, combined with its large craft workforce and execution capabilities, further strengthens its positioning. With AI accelerating electricity demand, Quanta could be positioned to capture a growing share of America's next infrastructure investment wave.

Quanta, EMCOR & AECOM: Which Stock Has More AI Fuel?Quanta is well-positioned to benefit from rising infrastructure spending and the growing power requirements of AI, alongside other market players, EMCOR Group, Inc. (EME - Free Report) and AECOM (ACM - Free Report) . PWR stands out with a record $53.4 billion backlog, supported by strong demand across utility generation, transmission and technology load centers. Management expects larger programs in these markets to build in the coming years, providing a strong foundation for revenue growth.

EMCOR benefits from robust backlog across electrical and mechanical construction, with data centers and other technology-related projects supporting demand for mission-critical infrastructure. AECOM, meanwhile, brings engineering, consulting and program-management expertise to large-scale infrastructure projects, positioning it to benefit from investments needed to expand power capacity and support AI-driven data center development.

Overall, Quanta offers the most direct exposure to the physical power infrastructure behind AI, while EMCOR and AECOM provide complementary construction and engineering capabilities. The three companies therefore have differentiated avenues to convert AI-related infrastructure spending and backlog strength into sustained revenue growth.

PWR Stock’s Price Performance & Valuation TrendPWR stock has gained 7.7% in the past six months, outperforming the Zacks Engineering - R and D Services industry and the Zacks Construction sector, but underperforming the S&P 500 index.

Image Source: Zacks Investment Research

PWR stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 34.14, as evidenced by the chart below.

Image Source: Zacks Investment Research

Earnings Estimate Revision of PWRPWR’s earnings estimates for 2026 and 2027 trended upward in the past 30 days to $16.37 per share and $18.96 per share, respectively. The revised estimates for 2026 and 2027 imply year-over-year growth of 52.3% and 15.8%, respectively.

Image Source: Zacks Investment Research

Quanta stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Folgers coffee maker J.M. Smucker (SJM.N) on Wednesday forecast a smaller-than-expected decline in annual sales, ​benefitting from steady demand for its ready-to-eat meals ‌and coffee.

Shares of the company rose about 4% premarket, after J.M. Smucker raised its annual profit forecast on the back ​of tariff-related refunds.

Here are some details:

Budget-conscious ​consumers, pressured by still-high inflation, are increasingly opting ⁠to eat at home rather than dining ​out, lifting demand for essential goods such as ​coffee and jams.

Easing coffee prices, which surged due to higher green coffee costs and tariffs in recent years, ​pushed J.M. Smucker to lower prices.

The company's quarterly gross ​profit increased to $504.9 million, which included tariff refunds of $115.0 million.

The company ‌forecast ⁠annual net sales to decrease by 1% to 2%, compared with its prior forecast of a 3% to 4% decline.

It expects full-year adjusted ​earnings to ​be between $10.50 ⁠and $11 per share, compared with its prior expectation of $9.75 to $10.25.

The Jif peanut butter maker's ​net sales for the quarter ended ​July ⁠31 stood at $2.22 billion, beating analysts' average estimate of $2.13 billion, according to data compiled by LSEG.

Excluding ⁠tariff refunds, it ​earned $3.24 per share on ​an adjusted basis during the first quarter, surpassing estimates of $2.22.

J. M. Smucker Today

SJM

J. M. Smucker

$132.13 +0.29 (+0.22%)

As of 08/28/2026 03:58 PM Eastern

$88.25▼

$135.893.39%

61.74

$136.25

J.M. Smucker's NYSE: SJM share price has rallied strongly since spring on a series of strong results, improving operational quality, and rotation back to high-yielding staples. The rally accelerated following the release of its Q1 fiscal year 2027 results, putting the market on track to cross a critical pivot point. The pivot is near $134.50, the highest price point set since the market gapped lower in late 2023. It is a likely target for strong resistance, representing a significant overhang that could cap gains.

However, the company shows clear strategic momentum and could break through. The question is what happens next, and a full price recovery is possible. In that scenario, the market signals a major change in dynamic in which selling pressure eases and accumulation drives share prices higher over time. Technically, the market could advance by an amount equal to the magnitude of the existing trading range, about $40, but this won’t happen all at once or quickly.

Get J. M. Smucker alerts:

The more likely outcome is a slow grind higher, with periodic stopping points for market consolidations and corrections, and the first trigger point isn’t all that high. It aligns with the top of the open price gap and may also be a strong point of market resistance.

Institutional and Analyst Tailwinds Remain StrongWall Street sentiment toward SJM was already favorable heading into the earnings release. MarketBeat tracks 19 analysts, with 10 Buy ratings and nine Holds, giving the stock a consensus Moderate Buy rating.

While SJM’s consensus price target showed no upside potential ahead of the release, the trend is upward. Summer activity included several boosted or reiterated price targets, pushing the high end to $142. A move to $142 would put this market above the high end of the open price window and well on its way to a more complete recovery.

Institutional activity reflects strong confidence in the value, outlook, and dividend payments, with the group owning more than 80% of the stock and continuing to accumulate shares. MarketBeat data reveals a greater than $2-to-$1 balance over the trailing 12-month period and a sharp spike in early Q3 ahead of the earnings report. Institutional activity foreshadowed the strong release, spiking to a multi-year high while sellers were virtually non-existent.

The J.M. Smucker Company Advances on Organic Strength and Pricing PowerSmucker’s posted a solid quarter, with strength across most segments supporting a 5% year-over-year (YOY) revenue gain. Revenue outperformed the consensus by a healthy 420 basis points, driven by pricing and volume/mix. Pricing improved by 4% and volume and mix by 1%, with most of the gains in the Coffee segment. Coffee grew by 13%, outpacing all others by a wide margin. Sweet Snacks is the weak link, declining 7% YOY but still contributing to margin.

Margin is one of the report's highlights. The company widened its margin significantly, helped by pricing, lower costs and approximately $115 million in tariff refunds. Key details include $425.7 million in cash flow and $337.3 million in free cash flow versus last year’s cash outflows and a 71% increase in adjusted earnings per share (EPS). EPS also outperformed the consensus by a wide margin, providing confidence in the new guidance.

Guidance is a catalyst for higher share prices. The company raised its revenue and earnings targets, now expecting revenue to decline by only 1% to 2% at the low end and earnings to come in well above prior forecasts. The new low-end target is above the prior high and the pre-report consensus, and may be cautious given the company’s momentum. Either way, the outlook is improved, including for dividend payments, and the dividend is substantial.

J. M. Smucker Dividend Payments3.39%

$4.48

27 Years

4.12%

209.35%

Sep. 1

SJM Dividend History

Institutional interest in this and other consumer staples stocks is driven by the dividend. The 2025/2026 sell-offs created deep-value opportunities while lifting yields to historical highs, and institutions are gobbling up shares. For SJM, the yield is running near 3.5% as of late August, and it is a reliable payment. Annualized distributions are running below 50% of the earnings forecast, cash flow is improving, and the company continues to reduce debt. Smucker still carries meaningful leverage, but improving cash flow and ongoing debt reduction support its ability to maintain financial health, sustain operations, and continue its streak of distribution increases. At 27 years, the company is a Dividend Champion on its way to becoming a Dividend King.

The company's biggest risk is integrating Hostess into its portfolio. More challenging than previously thought, the impact is reflected in the sweet segment performance. The upshot is Smucker's constructive engagement with activist Elliott Investment Management, which has focused on improving sales, profitability and capital discipline.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in J. M. Smucker Right Now?Before you consider J. M. Smucker, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and J. M. Smucker wasn't on the list.

While J. M. Smucker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Key Takeaways Humana's Medicare Advantage membership grew 23.8% year over year in the second quarter of 2026.CenterWell revenues rose 22.6% as Humana expanded its senior-focused primary care footprint.Rising medical costs and higher leverage are weighing on Humana's profitability and margins. Humana Inc. (HUM - Free Report) benefits from a strong care delivery model centered on value-based care, increasing premiums, strategic acquisitions, an aging population in the United States and solid cash generation capacity. HUM’s shares have surged 55.7% in the year-to-date period compared with the industry’s growth of 20.9%.

Humana offers health insurance benefits through Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. It also provides specialty products such as dental, vision and other supplementary benefits.

Courtesy of solid prospects, HUM currently carries a Zacks Rank #3 (Hold).

Where Do Estimates for HUM Stand?The Zacks Consensus Estimate for Humana’s 2026 earnings is pegged at $9.12 per share, which remained stable over the past seven days. Furthermore, the consensus mark for revenues is pegged at $162.6 billion for 2026, indicating a 25.3% year-over-year rise. It beat earnings estimates in each of the past four quarters, with an average surprise of 9.6%.

HUM’s Growth DriversHumana’s Medicare Advantage business remains a key growth engine, with membership expansion providing a foundation for improving the earnings potential of the portfolio. The company is also benefiting from stronger engagement among members. In the second quarter of 2026, total Medicare Advantage membership grew 23.8% year over year. Meanwhile, total premiums increased 26.4% year over year to $38.8 billion.

CenterWell is adding another growth avenue by expanding its senior-focused primary care footprint while using its pharmacy and home health businesses to build a more integrated care platform. The strategy combines organic patient growth with targeted acquisitions and greater integration across its care delivery businesses. CenterWell’s revenues increased 22.6% year over year in the second quarter of 2026.

The company is expanding its Medicaid footprint through the statewide Illinois contract scheduled to begin in January 2027, giving additional opportunities to diversify growth beyond its core Medicare Advantage business. HUM is using targeted capital allocation to strengthen its healthcare delivery capabilities. The planned divestiture of its minority stake in Gentiva, valued at approximately $900 million, is expected to largely fund the acquisition of MaxHealth. The transaction fits with Humana’s broader focus on expanding CenterWell and building a more integrated care platform.

Humana is also incorporating technology, automation and AI into its efforts to improve operating efficiency and simplify its business model. The company is transforming selected vendor relationships into more strategic technology-enabled partnerships while integrating acquired operations onto common platforms.

HUM’s solid financial position also provides flexibility to support growth and shareholder returns. As of June 30, 2026, the company had cash, cash equivalents and investment securities of $23.9 billion. It has been returning excess capital to its shareholders in the past several years. Humana repurchased common shares worth $108 million in the first half of 2026. It also paid a dividend of $214 million in the first half of 2026.

Key Concerns for HUM StockDespite its strengths, there are challenges to monitor.

Humana is facing rising medical cost intensity, which is weighing on profitability. Total operating expenses have steadily increased as a share of revenues, reaching 96.7% in second-quarter 2026 from 96.6% a year ago, indicating limited operating leverage. Operating expenses rose 26.3% year over year in the second quarter of 2026. The company expects the benefit ratio for the insurance segment to be 92.75%, with a variability margin of plus or minus 25 basis points for 2026, indicating an increase from the 2025 level of 90.4%.

Humana is grappling with a debt-laden balance sheet, which induces an increase in interest expenses. This might put pressure on the company’s margins. As of June 30, 2026, long-term debt was $12 billion. The company’s total debt-to-capital of 43.1% exceeds the industry average of 41.5%, underscoring higher leverage. Also, its forward P/E of 29.91X is higher than the industry average of 15.99X.

Stocks to ConsiderSome better-ranked stocks in the Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Globus Medical, Inc. (GMED - Free Report) and Centene Corporation (CNC - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.82 per share has witnessed six upward revisions in the past 30 days against no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 16.1%. The consensus estimate for current-year revenues is pegged at $15.3 billion, suggesting 18.2% year-over-year growth.

The Zacks Consensus Estimate for Globus Medical’s current-year earnings of $4.93 per share has witnessed three upward revisions in the past 30 days, against no movement in the opposite direction. GMED beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.9%. The consensus estimate for current-year revenues is pegged at $3.2 billion, suggesting 8.8% year-over-year growth.

The Zacks Consensus Estimate for Centene’s current-year earnings of $4.89 per share has witnessed nine upward revisions in the past 30 days, against no movement in the opposite direction. CNC beat earnings estimates in each of the trailing four quarters, with an average surprise of 151.3%. The consensus estimate for current-year revenues is pegged at $196.3 billion, suggesting 0.8% year-over-year growth.

Key Takeaways Labcorp is expanding specialty testing in oncology, women's health, autoimmune disease and neurology.Acquisitions and partnerships added to revenue growth and expanded Labcorp's health-system reach.Reimbursement changes and rising costs could pressure LH's Diagnostics utilization and profitability. Labcorp Holdings Inc. (LH - Free Report) , or Labcorp, is set to benefit from the expansion of its testing capabilities in strategic high-growth areas, including neurology and autoimmune disease. The company’s efforts to enhance its partnership with hospitals and health care systems have strengthened its footprint in important markets. Solid financial health also adds to the stock’s appeal. Yet, broader economic pressures and reimbursement-related headwinds may weigh on its results.

Over the past year, this Zacks Rank #3 (Hold) stock has risen 21.9% compared with the 13.4% growth of the industry and a 20.8% rise of the S&P 500 composite.

The renowned healthcare diagnostics company has a market capitalization of $27.28 billion. Labcorp’s earnings yield of 5.4% favorably compares with the industry’s 3.9% yield. In the trailing four quarters, the company delivered an average earnings surprise of 3.1%.

Let’s delve deeper.

Tailwinds for LabcorpTargeted Development in High-Growth Areas: Labcorp continues to expand in specialty testing areas such as oncology, women’s health, autoimmune disease and neurology. These areas delivered double-digit revenue growth during the first half of 2026 and helped the company win new health-system and provider customers.

In oncology, Labcorp launched ColoSense nationwide, expanded companion diagnostic access for prostate cancer and added an advanced DPYD genotyping test. It also entered into a clinical trial collaboration to evaluate Plasma Detect Genome MRD in patients at risk of early-stage lung cancer recurrence. The consumer business maintained double-digit growth, supported by Labcorp OnDemand, Marker by Labcorp and new at-home testing options. Specialty patients also tend to require more tests over time, supporting continued growth in tests per accession and favorable mix.

Image Source: Zacks Investment Research

Strategic Acquisitions and Partnerships to Drive Growth: Labcorp continues to build relationships with health systems and regional laboratories, expanding its patient network and access to specialty testing. During the second quarter of 2026, the company completed acquisitions of select Parkview Health outreach laboratory services and Tribal Diagnostics. It also secured another Department of Defense contract to provide testing across military hospitals worldwide.

Net acquisitions added 1.2% to enterprise revenue growth and 1.9% to Diagnostics growth during the quarter. The expanded collaboration with Epic also places more than 6,500 Labcorp tests on the Aura platform, simplifying access for healthcare providers and supporting deeper integration with health-system customers.

Solvency, Buybacks and Dividends: Labcorp ended the second quarter of 2026 with cash and cash equivalents of $141.8 million. Short-term borrowings and the current portion of long-term debt were $0.9 million, much lower than the cash level. The company also retired $500 million of senior notes during the quarter. Labcorp repurchased $353.8 million of stock and paid $58.7 million in dividends during the second quarter. In July 2026, the board increased the share-repurchase authorization by $1 billion, bringing the remaining authorization to $1.4 billion.

What Ails Labcorp?Macroeconomic and Cost Risks: Labcorp depends on testing demand from patients, physicians, hospitals and biopharmaceutical customers. Economic volatility, inflation, geopolitical disruption and tariffs can affect customer spending, supply costs and laboratory operations. The cost of revenues increased 5.6% year over year in the second quarter of 2026 and 5.4% during the first half. Although margins expanded, continued cost inflation could require further productivity gains or pricing actions to protect profitability. The biopharmaceutical business also remains exposed to changes in research budgets, study timing and customer funding, particularly within smaller biotech companies and Early Development programs.

Reimbursement and Cash Flow Constraints: Changes in government and third-party reimbursement remain a risk for the Diagnostics arm. Management estimated that Affordable Care Act-related changes reduced second-quarter 2026 diagnostic volume by 20-30 basis points and continues to assume a 30-basis-point full-year impact. The affected payer group represents less than 4-5% of diagnostic volume, but further coverage changes could weaken utilization or collections.

LH Stock Estimate TrendIn the past 30 days, the Zacks Consensus Estimate for Labcorp’s 2026 earnings per share (EPS) has edged up 1.6% to $18.28.

The Zacks Consensus Estimate for 2026 revenues is pegged at $14.75 billion, implying 5.7% growth relative to the 2025 figure.

Key PicksSome better-ranked stocks in the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and Teleflex (TFX - Free Report) .

Globus Medical has an earnings yield of 5.8% compared to the industry’s negative 1.7% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 27.9%. GMED shares have rallied 37% against the industry’s 2.7% decline over the past year.

GMED sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Veracyte, sporting a Zacks Rank #1, has an earnings yield of 4.6% against the industry’s negative 1.7% yield. Shares of the company have risen 40.3% against the industry’s 2.7% decline. VCYT’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 41.8%. 

Teleflex, carrying a Zacks Rank #2 (Buy), has an estimated long-term earnings growth rate of 20.7% compared with the industry’s 12.8% growth. Its earnings beat estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 3.2%. TFX shares have rallied 8.5% against the industry’s 2.7% decline over the past year.

Enterprise Products Partners (EPD -0.08%) has raised its quarterly distributions for 29 consecutive years, never once reducing its payout. Despite midstream energy's steadiness relative to other segments of the energy sector, a track record of zero dividend cuts or suspensions is quite rare among pipeline stocks. Other large pipeline master limited partnerships (MLPs), including Plains All American Pipeline and Energy Transfer, have had to cut their distributions in the past.

A key reason for Enterprise's strong record is its approach to cash flow distribution. By taking a more cautious approach, this MLP's unitholders could continue to benefit from its payout consistency.

Image source: Getty Images.

Enterprise Products Partners and its well-covered dividend In its quarterly earnings releases, Enterprise Products provides numerous financial metrics. One to pay particular attention to is the coverage of distributions ratio, which is distributable cash flow divided by distributions. Last quarter, this figure came in at 1.9x.

In other words, the MLP generated distributable cash flow nearly twice the size of distributions. With this high coverage, Enterprise is able to, on one hand, maintain and grow its nearly 5.75% dividend. At the same time, there's plenty of cash flow on hand to fund growth and expansion, reducing Enterprise Products Partners' need to borrow or issue additional MLP units.

Today's Change

(

-0.08

%) $

-0.03

Current Price

$

39.02

Keeping an eye on this metric Enterprise Products Partners is not for all investors. For those seeking stable gains, largely in the form of cash distributions, it's a solid opportunity. Keep in mind, however, that distribution growth has slowed down in recent years.

Moreover, if you do choose to buy Enterprise Product Partners, be sure to keep an eye on the coverage ratio. Each quarter, management presents this figure. If it starts to materially drop, it could be a sign that Enterprise is deviating from its historical approach, calling into question the sustainability of its future dividend growth.

With earnings season winding down, Movado Group (MOV - Free Report) ) and Nutanix (NTNX - Free Report) ) stand out as two highly ranked stocks worth watching ahead of their quarterly reports this week.

Both stocks currently sport a Zacks Rank #1 (Strong Buy), reflecting favorable earnings estimate revisions, and are scheduled to report on Wednesday, August 26.

Movado's Earnings Rebound and Lofty DividendMovado, one of the world’s premier watchmakers, will report its Q2 results before the market opens on Wednesday. The Zacks Consensus is calling for quarterly EPS of $0.36, which would be an impressive 56% year-over-year increase, with Q2 revenue expected to be up over 1% to $164.18 million.

The luxury watchmaker is coming off an encouraging Q1 in which sales increased 8% YoY to $142.4 million, adjusted EPS surged to $0.32 from $0.08 a year ago, and gross margin expanded 320 basis points to 57.3%. Movado also finished Q1 with $225.3 million in cash and no long-term debt, giving the company considerable financial flexibility. 

Reflecting its strong Q1 results and improving outlook, MOV has been one of the market’s better performers, with shares surging more than 60% year to date.

Image Source: Zacks Investment Research

Income investors have another reason to take notice. Movado recently raised its quarterly dividend 14% to $0.40 per share, or $1.60 annually. That equates to a lofty dividend yield of roughly 4.6%, with MOV trading at around $34 a share and at a reasonable 18X forward earnings multiple.

Image Source: Zacks Investment Research

Nutanix's Double-Digit Cloud GrowthNutanix will release results for its fiscal fourth quarter after the closing bell on Wednesday. The innovative tech company provides an enterprise cloud platform that combines compute, storage, virtualization, and networking into one integrated solution.

Q4 EPS is expected at $0.48, representing nearly 30% growth from the prior-year quarter, while revenue is projected to rise roughly 13% to $737.89 million. The Zacks Consensus also calls for full-year EPS of $1.93, up 19%, on more than 11% revenue growth to $2.83 billion.

Image Source: Zacks Investment Research

Nutanix's recurring-revenue momentum remains particularly attractive. Fiscal Q3 annual recurring revenue (ARR) climbed 15% YoY to $2.43 billion, while quarterly revenue rose 10% and non-GAAP operating margin expanded to 22.3% from 21.5%. Management subsequently raised its fiscal 2026 outlook to $2.82-$2.84 billion in revenue and $760-$780 million in free cash flow.

Wall Street will be looking for more of the same Wednesday, as Q4 ARR is expected to reach roughly $2.51 billion, compared with $2.22 billion a year ago.

Adding to Nutanix’s growth story is rising enterprise AI spending, with its hybrid-cloud infrastructure increasingly being used to deploy and manage GPU-powered generative and agentic AI workloads.

That expanding opportunity is helping justify NTNX’s 30X forward earnings multiple, with shares trading above $60 and up around 30% YTD to handily outperform many of its IT-services peers.

Image Source: Zacks Investment Research

Bottom LineMovado and Nutanix offer two different but attractive growth stories heading into earnings. NTNX provides exposure to durable hybrid-cloud and recurring-revenue growth, while MOV combines a sharp earnings recovery with a compelling dividend yield and a virtually debt-free balance sheet.

BlackRock Inc. purchased a new position in Penske Automotive Group, Inc. (NYSE:PAG – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 2,333,144 shares of the company’s stock, valued at approximately $417,516,000. BlackRock Inc. owned 3.55% of Penske Automotive Group at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Parallel Advisors LLC grew its holdings in Penske Automotive Group by 15.1% during the 1st quarter. Parallel Advisors LLC now owns 441 shares of the company’s stock valued at $66,000 after buying an additional 58 shares during the last quarter. Bessemer Group Inc. increased its position in Penske Automotive Group by 8.5% during the first quarter. Bessemer Group Inc. now owns 830 shares of the company’s stock worth $124,000 after purchasing an additional 65 shares during the last quarter. California State Teachers Retirement System raised its position in shares of Penske Automotive Group by 0.4% in the 2nd quarter. California State Teachers Retirement System now owns 18,434 shares of the company’s stock worth $3,167,000 after buying an additional 65 shares during the period. Rothschild Investment LLC lifted its stake in shares of Penske Automotive Group by 37.5% in the 4th quarter. Rothschild Investment LLC now owns 242 shares of the company’s stock valued at $38,000 after purchasing an additional 66 shares in the last quarter. Finally, Focus Partners Advisor Solutions LLC lifted its position in Penske Automotive Group by 2.7% during the fourth quarter. Focus Partners Advisor Solutions LLC now owns 2,630 shares of the company’s stock valued at $416,000 after buying an additional 70 shares in the last quarter. 77.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades Several research analysts have recently weighed in on PAG shares. JPMorgan Chase & Co. upped their target price on shares of Penske Automotive Group from $170.00 to $215.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Stephens boosted their price target on Penske Automotive Group from $166.00 to $210.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Morgan Stanley reaffirmed an “overweight” rating and set a $190.00 price objective on shares of Penske Automotive Group in a research report on Thursday, May 7th. Benchmark cut Penske Automotive Group from a “buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Finally, Bank of America raised their price target on shares of Penske Automotive Group from $200.00 to $238.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Penske Automotive Group has an average rating of “Moderate Buy” and an average price target of $208.50.

Read Our Latest Stock Analysis on PAG Penske Automotive Group Price Performance PAG opened at $219.59 on Wednesday. The firm has a market capitalization of $14.42 billion, a P/E ratio of 16.17, a PEG ratio of 2.90 and a beta of 0.84. The stock has a fifty day moving average of $201.67 and a 200-day moving average of $175.59. The company has a quick ratio of 0.21, a current ratio of 0.98 and a debt-to-equity ratio of 0.36. Penske Automotive Group, Inc. has a 12-month low of $140.12 and a 12-month high of $227.00.

Penske Automotive Group (NYSE:PAG – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $3.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.42 by $0.20. Penske Automotive Group had a net margin of 2.81% and a return on equity of 14.78%. The business had revenue of $8.51 billion during the quarter, compared to analyst estimates of $7.98 billion. During the same period in the prior year, the firm earned $3.78 earnings per share. The firm’s revenue was up 11.1% compared to the same quarter last year. Equities analysts forecast that Penske Automotive Group, Inc. will post 13.61 EPS for the current fiscal year.

Penske Automotive Group Increases Dividend The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Friday, August 14th will be paid a dividend of $1.44 per share. This is a boost from Penske Automotive Group’s previous quarterly dividend of $1.42. The ex-dividend date is Friday, August 14th. This represents a $5.76 annualized dividend and a dividend yield of 2.6%. Penske Automotive Group’s dividend payout ratio is currently 42.42%.

Insider Activity at Penske Automotive Group In other Penske Automotive Group news, CFO Michelle Hulgrave sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $171.80, for a total transaction of $257,700.00. Following the completion of the sale, the chief financial officer owned 17,596 shares of the company’s stock, valued at $3,022,992.80. This represents a 7.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 52.90% of the company’s stock.

(Free Report)

Penske Automotive Group, Inc (NYSE: PAG), headquartered in Bloomfield Township, Michigan, is an international transportation services company primarily focused on automotive and commercial truck dealerships. The company retails new and pre-owned vehicles across a broad spectrum of brands, while offering parts, maintenance, collision repair and reconditioning services. In addition, Penske provides financing and insurance products through its integrated finance and insurance operations, supporting both retail customers and commercial clients.

Formed in 1990 as United Auto Group and publicly traded since 1999, Penske Automotive Group has grown through organic expansion and strategic acquisitions to establish a network of dealerships and service centers across the United States and Europe.

Featured Articles Five stocks we like better than Penske Automotive Group Pathward’s Credit Scare Tests Its Comeback Story Wiring the AI Boom: Rumble’s $13.7B Pivot StoneX: Too Far Too Fast? DICK’s Sporting Goods Faces Pain Now for a Bigger Prize Want to see what other hedge funds are holding PAG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penske Automotive Group, Inc. (NYSE:PAG – Free Report).

Receive News & Ratings for Penske Automotive Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penske Automotive Group and related companies with MarketBeat.com's FREE daily email newsletter.

It has been about a month since the last earnings report for Asbury Automotive Group (ABG - Free Report) . Shares have lost about 15.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Asbury Automotive due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Asbury Automotive Group, Inc. before we dive into how investors and analysts have reacted as of late.

Asbury Q2 Earnings Top ExpectationsAsbury reported second-quarter 2026 adjusted earnings of $6.82 per share, which declined 8.2% year over year but exceeded the Zacks Consensus Estimate of $6.30 by 8.25%. The bottom-line beat reflected stronger used-vehicle profitability despite weaker new-vehicle margins. Revenues of $4.38 billion rose 0.3% from the prior-year quarter but missed the consensus mark of $4.46 billion by 1.78%.

Revenue MixNew-vehicle revenues increased 1% year over year to $2.33 billion, while used retail revenues declined 3% to $1.09 billion. Wholesale used-vehicle revenues fell 9% to $141.9 million, leaving total used-vehicle revenues down 4% at $1.24 billion.

Parts and service revenues advanced 6% to $634.6 million, while finance and insurance revenues edged up 1% to $183.8 million. The revenue mix shifted modestly toward parts and service, which represented 14.5% of total revenues compared with 13.8% a year earlier.

Vehicle EconomicsNew-vehicle unit sales were nearly flat at 44,245 units. Luxury and import sales increased 6% and 5%, respectively, but domestic unit sales declined 15%. The average new-vehicle selling price rose 2% to $52,666. Despite the pricing gain, new-vehicle gross profit fell 14% to $138.2 million as gross profit per unit declined 13% to $3,124.

Used retail unit sales decreased 9% to 33,098, while the average selling price increased 6% to $33,054. Used retail gross profit rose 6% to $66.2 million, supported by the 16% improvement in gross profit per unit. Wholesale gross profit dropped 54% to $3.1 million.

Parts and service gross profit increased 5% to $374.2 million, making it the company’s largest gross profit contributor. Finance and insurance gross profit rose 2% to $171.4 million, with gross profit per vehicle retailed increasing 6% to $2,216.

Total gross profit was $753.1 million, essentially flat year over year, while gross margin remained at 17.2%.

Same-Store Operations Remain SoftSame-store revenues declined 7% to $3.76 billion, while same-store gross profit decreased 7% to $643.2 million.

New-vehicle unit sales fell 6% to 38,908, and used retail unit sales declined 14% to 28,821.

Same-store new-vehicle gross profit per unit dropped 18% to $2,896. In contrast, used retail gross profit per unit increased 10% to $1,927, and finance and insurance gross profit per vehicle retailed rose 5% to $2,214. Same-store parts and service gross profit declined 1% to $322.8 million.

Other TidbitsSelling, general and administrative expenses rose 7% to $506.4 million. Adjusted SG&A increased 4% to $496.7 million and represented 66% of gross profit, compared with 63.6% in the year-ago quarter.

Income from operations declined 15% to $219.5 million. Adjusted operating margin contracted to 5.3% from 5.8%, while adjusted EBITDA decreased to $234.8 million from $255.8 million. The results reflected higher expenses and weaker new-vehicle economics.

The company generated $305.2 million of adjusted operating cash flow during the first half of 2026 and reported adjusted free cash flow of $188 million. It ended June with $966 million of liquidity and a transaction-adjusted net leverage ratio of 3.4 times.

ABG repurchased about 668,000 shares for $131 million during the quarter. Year to date, it bought back roughly 1.35 million shares for $278 million, leaving approximately $322 million under its authorization.

Asbury Advances Its Tekion RolloutAsbury had converted 70% of its stores to the Tekion dealership management system as of July 28 and expects to complete the rollout in fall. Management noted stronger productivity, customer-pay performance, technician efficiency and sales effectiveness in markets that had used the platform for at least five months.

In June, the Koons, Georgia and Florida stores increased average units per salesperson by 12% and dollars per technician by 10%. Management expects the platform to support better operating efficiency and is targeting same-store adjusted SG&A as a percentage of gross profit in the low-60% range by the end of 2027.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.

The consensus estimate has shifted 5.13% due to these changes.

VGM ScoresCurrently, Asbury Automotive has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. However, the stock was allocated a grade of A on the value side, putting it in the top quintile for value investors.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, Asbury Automotive has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.